Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.
Anderson
K E
KE
Girdwood
A C
AC
Wilson
J A
JA
D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects*
D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa